Related Experiment Video
Updated: May 7, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
A silent nucleotide substitution in the ATP7A gene in a child with Menkes disease
Lisbeth Birk Møller1, Gillian Rea, Saiqa Yasmeen
1Center for Applied Human Genetics, Kennedy Center, Gl. Landevej 7, 2600 Glostrup, Denmark.
Abstract:
We present a case of classical Menkes disease (MD) due to a novel "silent" substitution in the ATP7A gene; c.2781G>A (p.K927K). The affected nucleotide is the last nucleotide in exon 13, and affects mRNA splicing. Transcripts missing exon 13; and transcripts missing exons 11, 12 and 13 in addition to a very small amount of normal spliced ATP7A transcripts were expressed. This is the first report of a synonymous ATP7A substitution being responsible for MD.
Insights
Researchers identified a new cause of classical Menkes disease (MD) linked to a silent mutation in the ATP7A gene. This discovery highlights how synonymous ATP7A gene substitutions can lead to this rare neurological disorder.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Menkes disease (MD) is a rare X-linked neurodegenerative disorder.
- It is typically caused by mutations in the ATP7A gene, affecting copper transport.
- Classical MD presents with severe neurological impairment and connective tissue abnormalities.
Purpose of the Study:
- To report a novel synonymous ATP7A gene substitution causing classical Menkes disease.
- To investigate the molecular mechanism by which this substitution leads to MD.
- To expand the understanding of genotype-phenotype correlations in Menkes disease.
Main Methods:
- Genetic sequencing of the ATP7A gene in a patient with classical MD.
- Analysis of mRNA splicing patterns using RT-PCR.
- In silico prediction of splicing effects.
Main Results:
- A novel synonymous substitution, c.2781G>A (p.K927K), was identified in the ATP7A gene.
- This substitution, located at the last nucleotide of exon 13, disrupted normal mRNA splicing.
- Aberrant transcripts lacking exon 13, or exons 11-13, were detected, with minimal normal transcript levels.
- This is the first reported case of a synonymous ATP7A substitution causing Menkes disease.
Conclusions:
- Synonymous ATP7A gene substitutions can act as causative mutations for classical Menkes disease.
- Disruption of mRNA splicing is a key mechanism leading to MD in this case.
- This finding broadens the spectrum of mutations associated with Menkes disease and emphasizes the importance of evaluating splicing effects for synonymous variants.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
ATP Synthase: Mechanism
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
ATP Synthase: Structure
Point and Frameshift Mutations
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...